| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.32 |
2e-12 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
6e-07 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
4e-06 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-05 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.0001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |